Literature DB >> 20223923

The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis.

Soizic Guihard1, Denis Clay, Laurence Cocault, Nathalie Saulnier, Paule Opolon, Michèle Souyri, Gilles Pagès, Jacques Pouysségur, Françoise Porteu, Murielle Gaudry.   

Abstract

The mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinase 1 (ERK1) and ERK2 are among the main signal transduction molecules, but little is known about their isoform-specific functions in vivo. We have examined the role of ERK1 in adult hematopoiesis with ERK1(-/-) mice. Loss of ERK1 resulted in an enhanced splenic erythropoiesis, characterized by an accumulation of erythroid progenitors in the spleen, without any effect on the other lineages or on bone marrow erythropoiesis. This result suggests that the ablation of ERK1 induces a splenic stress erythropoiesis phenotype. However, the mice display no anemia. Deletion of ERK1 did not affect erythropoietin (EPO) serum levels or EPO/EPO receptor signaling and was not compensated by ERK2. Splenic stress erythropoiesis response has been shown to require bone morphogenetic protein 4 (BMP4)-dependent signaling in vivo and to rely on the expansion of a resident specialized population of erythroid progenitors, termed stress erythroid burst-forming units (BFU-Es). A great expansion of stress BFU-Es and increased levels of BMP4 mRNA were found in ERK1(-/-) spleens. The ERK1(-/-) phenotype can be transferred by bone marrow cells. These findings show that ERK1 controls a BMP4-dependent step, regulating the steady state of splenic erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223923     DOI: 10.1182/blood-2009-09-242487

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression.

Authors:  Juxing Chen; Caroline A Enns
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

2.  Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.

Authors:  Seema Singh; Arvind Dev; Rakesh Verma; Anamika Pradeep; Pradeep Sathyanarayana; Jennifer M Green; Aishwarya Narayanan; Don M Wojchowski
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

3.  ROCK1 functions as a critical regulator of stress erythropoiesis and survival by regulating p53.

Authors:  Sasidhar Vemula; Jianjian Shi; Raghuveer Singh Mali; Peilin Ma; Yan Liu; Philip Hanneman; Karl R Koehler; Eri Hashino; Lei Wei; Reuben Kapur
Journal:  Blood       Date:  2012-08-13       Impact factor: 22.113

4.  A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.

Authors:  Helena Frey; Kristin Moreth; Louise Tzung-Harn Hsieh; Jinyang Zeng-Brouwers; Birgit Rathkolb; Helmut Fuchs; Valérie Gailus-Durner; Renato V Iozzo; Martin Hrabě de Angelis; Liliana Schaefer
Journal:  Glycoconj J       Date:  2016-09-06       Impact factor: 2.916

Review 5.  Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.

Authors:  Eva Chung; Motonari Kondo
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

6.  Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways.

Authors:  Miroslav Koulnis; Ermelinda Porpiglia; P Alberto Porpiglia; Ying Liu; Kelly Hallstrom; Daniel Hidalgo; Merav Socolovsky
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

7.  Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.

Authors:  Alessandro Matte; Enrica Federti; Michael Winter; Annette Koerner; Anja Harmeier; Norman Mazer; Tomas Tomka; Maria Luisa Di Paolo; Luigia De Falco; Immacolata Andolfo; Elisabetta Beneduce; Achille Iolascon; Alejandra Macias-Garcia; Jane-Jane Chen; Anne Janin; Christhophe Lebouef; Franco Turrini; Carlo Brugnara; Lucia De Franceschi
Journal:  JCI Insight       Date:  2019-11-14

8.  Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis.

Authors:  Jing Liu; Jianhua Zhang; Yelena Ginzburg; Huihui Li; Fumin Xue; Lucia De Franceschi; Joel Anne Chasis; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

9.  Macrophage migration inhibitory factor is an endogenous regulator of stress-induced extramedullary erythropoiesis.

Authors:  Sanja Vignjević Petrinović; Mirela Budeč; Dragana Marković; Mirjana Gotić; Olivera Mitrović Ajtić; Slavko Mojsilović; Stanislava Stošić-Grujičić; Milan Ivanov; Gordana Jovčić; Vladan Čokić
Journal:  Histochem Cell Biol       Date:  2016-04-30       Impact factor: 4.304

Review 10.  Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.

Authors:  Nicole Rainville; Edward Jachimowicz; Don M Wojchowski
Journal:  Expert Opin Ther Targets       Date:  2015-09-30       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.